Press release year list 2023 2022 2021 2020 2019 2018
05/24/2023
Eterna Therapeutics Appoints Megan Yung as Chief Strategy Officer, General Counsel
05/17/2023
Eterna Therapeutics and Factor Bioscience Announce New Data on Multi-Cell-Type Therapeutic Approach at American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting
05/04/2023
Eterna Therapeutics to Deliver Eight Presentations at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting
05/02/2023
Eterna Therapeutics Acquires Allogeneic Immuno-Oncology Platform from Exacis Biotherapeutics
04/11/2023
Eterna Therapeutics and Lincoln Park Capital Enter into a Common Stock Purchase Agreement for Up To $10 Million
03/28/2023
Jeff Karp, Ph.D., Joins Eterna’s Scientific Advisory Board
03/20/2023
Eterna Therapeutics Reports Financial Results for Fourth Quarter and Full Year 2022 and Recent Business Highlights
02/22/2023
Eterna Therapeutics Enters Into Option and License Agreement with Lineage Cell Therapeutics to Develop Hypoimmune Pluripotent Cell Lines for Multiple Neurology Indications
01/04/2023
Eterna Therapeutics Appoints Matt Angel, Ph.D. as Chief Executive Officer and President